pitchbook.com Open in urlscan Pro
35.188.102.109  Public Scan

Form analysis
1 forms found in the DOM

/profiles/search

<form action="/profiles/search" class="search-form d-inline-block M-12 S-0" role="search" __bizdiag="113" __biza="WJ__">
  <input type="text" name="q" value="" maxlength="200" title="Text for search" aria-label="Text for search" class="offset-top-XL-15 offset-bottom-XL-15 lighter-border-color search-input search-input_lighter search-form__input"
    placeholder="Search profile previews">
  <button type="submit" aria-label="Search button" class="btn-search search-form__submit"></button>
  <span data-btn-search-collapsed="" class="XL-0 d-block-S icon-profile-close secondary-text search-form__close offset-left-XL-10 offset-right-XL-10 offset-top-XL-5 offset-bottom-XL-5 d-block-S"></span>
</form>

Text Content

Log in Request a free trial
 * 
 * Request a free trial Log in
 * Products
 * Solutions
 * Data
 * News & Analysis
 * About
 * Blog


BOSTONGENE



THIS IS A PROFILE PREVIEW FROM THE PITCHBOOK PLATFORM.

Request a free trial

Are you a startup? Learn more about PitchBook

 * Overview
 * Timeline
 * Valuation & Funding
 * Cap Table
 * Comparisons
 * Competitors
 * Patents
 * Team
 * Board Members
 * Service Providers
 * Signals
 * Investors
 * Lead Partners on Deals
 * Acquisitions
 * Subsidiaries
 * Exits


BOSTONGENE OVERVIEW

Update this profile
 * Founded
 * 2015


 * Status
 * Private

 * Employees
 * 234


 * Latest Deal Type
 * Series B

 * Latest Deal Amount
 * $150M


 * Investors
 * 3


BOSTONGENE GENERAL INFORMATION


DESCRIPTION

Developer of biomedical software designed for advanced patient analysis and
personalized therapy. The company's solution performs analytics for each
patient's individual genetics, tumor and tumor microenvironment, clinical
characteristics and disease profile, providing aid to clinicians in their
evaluation of viable treatment options.


CONTACT INFORMATION

Website
www.bostongene.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Primary Office
 * University Office Park III 95 Sawyer Road
 * Suite 500
 * Waltham, MA 02453
 * United States

+1 (617) 000-0000





BOSTONGENE TIMELINE

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

WANT DETAILED DATA ON 3M+ COMPANIES?

What you see here scratches the surface


Request a free trial
Looking for startup resources?
Visit PitchBook for startups.

WANT TO DIG INTO THIS PROFILE?

We’ll help you find what you need

Learn more


BOSTONGENE VALUATION & FUNDING

Deal Type Date Amount Raised to Date Post-Val Status Stage 2. Later Stage VC
(Series B) 06-Apr-2022 $150M 00000 Completed Generating Revenue 1. Early Stage
VC (Series A) 24-Apr-2019 0000 0000 Completed Startup

To view BostonGene’s complete valuation and funding history, request access »


BOSTONGENE COMPARISONS

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of biomedical software designed for advanced patient analysis and
personalized therapy. The company's solution
Decision/Risk Analysis
Waltham, MA
234 As of 2022
00000

00000000000 00000


000000 0

cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non
proident, sunt in cul
0000000000000 00000000
Chicago, IL
0000 As of 0000
00.000

00000000


0000000

sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad
minim veniam, quis no
0000000000000 00000000
San Francisco, CA
00 As of 0000
0000
0000 0000-00-00
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for
similar companies. Personalize which data points you want to see and create
visualizations instantly.

Request a free trial



BOSTONGENE COMPETITORS (23)

Company Name Financing Status Location Employees Total Raised Last Financing
Date/Type Last Financing Amount Tempus Labs Venture Capital-Backed Chicago, IL
0000 00.000 00000000 0000000 Venture Capital-Backed San Francisco, CA 00 0000
00000000000 0000 00000000 Formerly PE-Backed Harderwijk, Netherlands 00 000000 -
000 000000000 Venture Capital-Backed San Francisco, CA 00 000.00 00000000000
000.00 00000000 Venture Capital-Backed Atlanta, GA 00 00.000 00000000000 00.000

You’re viewing 5 of 23 competitors. Get the full list »


BOSTONGENE PATENTS


 * 81
   
   Total Documents Applications and Grants


 * 000
   
   Total Patents Families


 * 1
   
   Granted


 * 5
   
   Pending


 * 000
   
   Expiring in next 12 mo




BOSTONGENE RECENT PATENT ACTIVITY

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210287759-A1 Systems and methods for deconvolution of expression data
Pending 12-Mar-2020 000000000 US-20210279866-A1 Machine learning image
processing techniques Pending 06-Mar-2020 00000000000 US-20210174899-A1 Machine
learning techniques for gene expression analysis Pending 05-Dec-2019 000000000
US-20210005284-A1 Techniques for nucleic acid data quality control Pending
03-Jul-2019 0000000000 US-20210005283-A1 Techniques for bias correction in
sequence data Pending 03-Jul-2019 C12Q1/6806

To view BostonGene’s complete patent history, request access »


BOSTONGENE EXECUTIVE TEAM (2)

Update this profile

Name Title Board Seat Contact Info Andrew Feinberg President & Chief Executive
Officer Nathan Fowler MD Chief Medical Officer

To view BostonGene’s complete executive team members history, request access »


BOSTONGENE SIGNALS

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth
using web presence and social reach.

Request a free trial



BOSTONGENE INVESTORS (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact
Info Impact Investment Capital Impact Investing Minority 000 0000 000000 0 Japan
Industrial Partners PE/Buyout Minority 000 0000 000000 0 NEC Corporation
Corporation Minority 000 0000 000000 0

To view BostonGene’s complete investors history, request access »

Ready to get started?

Request a free trial


PRODUCTS

 * PitchBook Desktop
 * PitchBook Mobile
 * CRM Integration
 * Excel Plugin
 * Chrome Extension
 * Direct Data
 * Institutional Research Group
 * Product Releases


PITCHBOOK FOR

 * Private Market Valuations
 * Benchmarks
 * Startups
 * Venture Capital


PROFILE PREVIEWS


SOLUTIONS

 * Private Market Intel
 * Fundraising
 * Deal Sourcing
 * Due Diligence
 * Business Development
 * Networking
 * Deal Execution


BLOG


WEBINARS


VIDEO LIBRARY


DATA

 * Companies
 * Investors
 * Deals
 * M&A
 * Limited Partners
 * Funds
 * Financials
 * Advisors
 * Professionals
 * Debt
 * Lenders
 * Data Operations


NEWS & ANALYSIS

 * Reports
 * Newsletter
 * Advertise
 * Research & Analysis Team


ABOUT

 * Customer Success
 * Client Testimonials
 * What Sets Us Apart
 * Press Inquiries
 * Partnerships
 * Careers


FOLLOW US

 * 
 * 
 * 
 * 
 * 


US HEADQUARTERS

 * +1 (206) 623.1986
 * 901 Fifth Avenue
 * Suite 1200
 * Seattle, WA 98164


EUROPEAN HEADQUARTERS

 * +44 (0) 20 8037.2308
 * 1st Floor Saffron House
 * 6-10 Kirby Street
 * London EC1N 8TS
 * United Kingdom


ASIA-PACIFIC HEADQUARTERS

 * Unit 6807-09, The Center
 * 99 Queen’s Road Central
 * Hong Kong


CONTACT US

 * info@pitchbook.com
 * Request Research
 * Profile Request
 * Deal Submission
 * GDPR Compliance


FOLLOW US

 * 
 * 
 * 
 * 
 * 

© 2022 PitchBook Data. All rights reserved. PitchBook is a financial technology
company that provides data on the capital markets.

 * Terms of Use
 * Privacy Policy







We need your consent to proceed to PitchBook
Our site uses cookies and other technologies to improve your experience and
understand how you and other visitors use our site.
You can configure your preferences at any time using the cookie policy tool.
When you access our site, the companies listed in our cookie policy will use
cookies on our site.
Agree and Enter
Close  ✖